GPX4 and prostate cancer: In vitro ferroptosis in prostate cancer cells has been demonstrated to be triggered by downregulation of circDUSP22; the mechanism of action is associated with the suppression of the SLC7A11/GPX4 signaling pathway (Fig. 11).